Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Teladoc Health, Inc. (TDOC) had Revenue of $626.44M for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$626.44M
Net Income	$-49.51M
Cost of Goods Sold	$187.18M
Gross Profit	$439.26M
Operating Expenses	$678.40M
Operating Income	$-51.96M
Non-Operating Income/Expense	$1.74M
Pre-Tax Income	$-50.22M
Normalized Pre-Tax Income	$-50.22M
Income after Taxes	$-49.51M
Income from Continuous Operations	$-49.51M
Consolidated Net Income/Loss	$-49.51M
Normalized Income after Taxes	$-49.51M
EBIT	$-51.96M
EBITDA	$52.81M
Weighted-Average Shares Outstanding (Basic)	176.94M
Weighted-Average Shares Outstanding (Diluted)	176.94M
Earnings per Share (EPS) (Basic)	$-0.28
Earnings per Share (EPS) (Diluted)	$-0.28
Balance Sheet Financials
Current Assets	$1.09B
Property, Plant, and Equipment	$26.92M
Long-Term Assets	$1.79B
Total Assets	$2.88B
Current Liabilities	$405.09M
Long-Term Debt	$994.04M
Long-Term Liabilities	$1.08B
Total Liabilities	$1.49B
Common Equity	$1.39B
Tangible Shareholders Equity	$-227.73M
Shareholders Equity	$1.39B
Common Shares Outstanding	177.35M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$206.62M
Cash Flow from Investing Activities	$-231.68M
Cash Flow from Financial Activities	$-552.76M
Beginning Cash	$1.30B
End Cash	$726.25M
Increase/Decrease in Cash	$-572.08M
Stock-Based Compensation	$64.50M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.70
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.42
Debt to Equity Ratio	0.71
Gross Margin	70.12%
Operating Margin	-8.29%
EBIT Margin	-8.29%
EBITDA Margin	--
Pre-Tax Profit Margin	-8.02%
Profit Margin	-7.90%
Free Cash Flow	$113.48M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.22
Inventory Turnover	4.69
Receiveable Turnover	2.97
Days Sales in Receivables	30.28
Return on Equity	-3.56%
Return on Tangible Equity	21.74%
Return on Assets	-1.72%
Return on Investments	-2.07%
Book Value Per Share	$7.85
Free Cash Flow per Share	$0.64
Operating Cash Flow per Share	$1.17

Data from Zacks Investment Research, Inc.